Avatar for Lerer Hippeau

The most active early-stage investor in NYC

The most active early-stage investor in NYC

Lerer Hippeau is an early-stage venture capital fund based in New York City. As founders and operators ourselves, we see returns in relationships.

We seek entrepreneurs with product vision, consumer insight, focused execution, and unwavering ambition. When we are lucky enough to meet such people, our hope is that they will choose us as a long-term partner.

Lerer Hippeau hasn't added any jobs yet

Get notified when Lerer Hippeau posts new jobs.

See similar jobs

Latest Stories and News

The Q1 2020 global VC report: Funding slowly impacted by coronavirus

  • Crunchbase News
  • 1 month ago
  • Crunchbase projects 7,600 venture rounds generated in Q1 2020, down from the last quarter by 5 percent and down year over year by 4 percent.
  • Since the first quarter of 2018, total projected venture deal volume has been above 7,000 rounds per quarter peaking at around 8,500 in the second quarter of 2019. That makes 7,600 rounds the lowest projected count in the last five quarters.
  • Around $63.8 billion was invested worldwide in Q1 2020, down from the last quarter by 17 percent and down year over year by 8 percent.
  • Approximately $3.3 billion was invested across 4,896 deals in Q1 2020 in seed-stage deals. Seed-stage rounds include angel, pre-seed, seed and a subset of rounds below a certain threshold.
The Q1 2020 global VC report: Funding slowly impacted by coronavirus

K Health raises $48 million to apply AI to telemedicine

  • VentureBeat
  • 3 months ago
  • K Health, a NYC- and Tel Aviv, Israel-based AI powered telemedicine company, closed a $48m series C funding.
  • The round was led by 14W and Mangrove Capital with participation from Anthem, Lerer Hippeau and Primary Venture Partners.
  • The company intends to use the funds to grow its telemedicine offering and translate the platform in Spanish.
  • K Health provides an app that allows patients to check their symptoms and chat with a doctor. The company’s platform ingests medical histories, clinical outcomes, and the collective experience of more than 10,000 doctors to deliver treatment information on hundreds of diseases.
  • The app asks questions about symptoms and accounts for age, gender, and medical history as it investigates health of a user. Quickly, the user will see how people in the same demographic group were diagnosed and treated by doctors when they were in the same situation. Users can chat with the doctor on call throughout a health episode for a diagnosis, advice, prescriptions and lab test orders.

Soylent shakes up its executive team, naming Demir Vangelov as its new CEO

  • TechCrunch
  • 3 months ago
  • Soylent, the once high-flying Los Angeles-based meal replacement startup that has raised $72.4 million in financing from investors including Google Ventures, Lerer Hippeau and Andreessen Horowitz, has shaken up its executive team.
  • This week, the company announced in a blog post that the company’s chief financial officer, Demir Vangelov, would be taking over the top spot at the company and current chief executive Bryan Crowley would be stepping down.
  • Vangelov, who’s taking over from Crowley, previously served as an executive at the milk alternative company Califia Foods and at Oberto Foods, so he knows consumer packaged brands.
Soylent shakes up its executive team, naming Demir Vangelov as its new CEO
Helping early stage companies hire, grow, and scale.

Natalie Sportelli

Avatar for Natalie Sportelli
Content & Brand Manager at Lerer Hippeau

Isabelle Phelps

Avatar for Isabelle Phelps
Investor at @Lerer Hippeau